Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis

prnasiaJuly 20, 2020

Tag: Biopharma Initiates , CBP-201 , Moderate-to-Severe Atopic Dermatitis

PharmaSources Customer Service